Our People

Tyra has built a nimble and experienced team to rapidly translate new discoveries into the clinic with a singular focus on acquired resistance in oncology.

Board Members

Bob More
Sid Subramony
Todd Harris
Gilla Kaplan
Nina Kjellson
Isan Chen
Jake Simson

Company

Robert L. Hudkins
Esther van den Boom
Lindy Schermerhorn
Dan Bensen
Todd Harris
Mike Riley
Ronald V. Swanson
Jane Arboleda
Piyush Patel

Scientific Advisors

Jeffrey Hager
William Hahn
Jason Sheltzer

Investors

venture-Alta
venture-RA-Capital
venture-Boxer-Capital
venture-Canaan